Data are beginning to provide a clearer picture of chimeric antigen receptor T-cell therapy’s benefits and risks in lupus, ...
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute. In vivo CAR T-cell therapy could drastically ...
Researchers have discovered how mitochondrial stress drives T cell exhaustion and a potential way to restore their ...
India Today on MSN
CAR-T therapy, used for cancer, shows promise in treating lupus
For patients who have spent years managing unpredictable and debilitating autoimmune conditions like lupus, the findings ...
SHANGHAI and NANJING, China and PLEASANTON, Calif., March 24, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, ...
BCMA CAR T approvals (ide-cel 2021; cilta-cel 2022) deliver near-98% response in trials but require specialized centers, creating logistical constraints on access. Across >9 million UC patients, ...
CAR T-cell therapy re-engineers immune cells to target and eradicate high-risk blood cancers, offering potential cures where traditional chemotherapy fails. Initially requiring inpatient care due to ...
CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Identifying tumor-selective antigens like CDH17, GD2, and ...
A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...
Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...
The curious minds at ColdFusion break down CAR-T therapy designed to target and kill cancer cells. Republicans pull off shock result in Virginia special election Contributor: Ukraine's aid against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results